Medicine
Korsuva 65 mcg/1.3 mL injection
Korsuva 65 mcg/1.3 mL injection is a prescription medicine containing Difelikefalin for intravenous use, marketed by Vifor (International), with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Do not freeze. Store vials at 20°C to 25°C (68°F to 77°F), excursions…
Key facts
- Active ingredient (INN)
- Difelikefalin
- Brand
- Korsuva
- Strength
- 65 mcg/1.3 mL
- Dosage form
- Injection
- Route
- Intravenous
- Packs
- 12 vials of 1.3 mL
- Marketing authorisation holder
- Vifor (International)
- Manufacturer
- Vifor (International)
- Origin register
- US FDA, United States
- Storage
- Do not freeze. Store vials at 20°C to 25°C (68°F to 77°F), excursions permitted to 15°C to 30°C (59°F to 86°F). KORSUVA injection must be administered within 4 hours of syringe preparation, prepared syringes can be stored at ambient temperature 20°C to 25°C (68°F to 77°F) until dosing.
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- V03AX Antidotes and other therapeutic products, subgroup V03A, subgroup V03AX
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 1 November 2021
- Identifiers
- RxCUI 2569094, 2569100DailyMed set ID 0c7b81f2-0fd3-47cb-8b0f-185e07f19c87NDC 59353-065Application NDA214916
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 12 vial, single-use in 1 tray / 1.3 mL in 1 vial, single-use | 59353-065-12 | Vifor (International) | 1 November 2021 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Clinical summary
Difelikefalin is a kappa opioid receptor agonist indicated for the treatment of moderate-to-severe pruritus associated with chronic kidney disease (CKD-aP) in adults undergoing hemodialysis (HD). It is available as injection for intravenous use. MedsAcross supplies Difelikefalin for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about DifelikefalinFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Korsuva prescribing information (Vifor (International)) · U.S. National Library of Medicine, DailyMed
- Kapruvia: European public assessment report (EPAR) · European Medicines Agency
Need Korsuva 65 mcg/1.3 mL injection for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.